Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Q3 earnings expectations and the first full quarter of Northern Data/Quake AI revenue dominate discussion, with traders weighing acquisition-driven growth against questions about margins, cash needs, and potential dilution. Some also point to elevated short interest as possible squeeze fuel, while others remain skeptical about execution and the reported Anthropic arrangement.

CoreWeaves Q3 revenue beat, raised outlook, and customer prepayment and financing plans have eased some concerns about funding its AI infrastructure expansion, prompting a sharp bullish reaction and speculation about short covering. Traders remain divided over whether strong demand and backlog can overcome the companys heavy debt, high interest costs, and continued losses.

Rigettis quarterly results missed expectations and its 2026 revenue outlook fell short, fueling concerns about its valuation and how long commercialization may take. Bulls point to quantum-hardware progress and government support, while skeptics question whether those milestones will translate into paying customers and repeat revenue.

Nvidias sharp selloff and volatile rebound are centered on scrutiny of CEO Jensen Huang over allegations tied to China chip shipments, alongside a Baird downgrade. Traders disagree on whether the controversy and potential investigations threaten the company, while bullish voices argue AI demand remains strong, pointing to CoreWeaves results and Nvidias upcoming earnings as counterpoints.

Ousters quarterly results, including strong revenue and sensor-shipment growth, have focused attention on demand for its lidar and Stereolabs cameras across robotics and other Physical AI applications. Traders are mostly upbeat about the operating momentum, but debate the outlook and margin pressure, while some attribute the volatile share-price reaction to broader weakness in AI and growth stocks.

SOXX is drawing attention amid a sharp, volatile semiconductor selloff as traders question whether data-center expansion and AI spending can sustain chip demand, with regulatory and financing concerns adding to the pressure. The community is split between buying what it sees as an oversold dip and expecting further declines; scrutiny of Nvidias CEO is another source of uncertainty for the AI-heavy sector.

Netlists Q3 results and conference call have drawn attention, with traders focusing on its Samsung and Micron licensing agreements and managements outlook for higher operating income and product sales in Q4. Some interpret the CEOs comments as hinting at a possible SK Hynix license, while others point to the results falling short of estimates and lower sequential product sales; a Hynix deal remains speculation.

Amentums repeated government contract wins across defense, NASA and nuclear work are fueling discussion, but traders are frustrated that the announcements have not consistently lifted the shares. Bulls point to the growing backlog and low valuation, while skeptics focus on weak growth, margins, debt and the stocks persistent underperformance.

Costcos record special dividend and renewed share-repurchase authorization are driving attention, with many traders celebrating the shareholder payout and others arguing the stock remains expensive or that the dividend is not free money.

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with the company reaffirming confidence in the therapy and saying its application is in final review ahead of the November 22 target date. Many traders read managements comments and launch preparations as encouraging, while others warn that approval is uncertain given the FDAs prior concerns and the binary regulatory risk.